The Impact of Aberrant Data Variability on Drug–Placebo Separation and Drug/Placebo Response in an Acute Schizophrenia Clinical Trial

OBJECTIVE: In the current posthoc analyses, we evaluated the impact of markers of aberrant data variability on drug placebo separation and placebo and drug response in an acute schizophrenia clinical trial. METHODS: Positive and negative syndrome scale data were obtained from a phase 2, randomized,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kott, Alan, Brannan, Stephen, Wang, Xingmei, Daniel, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Regular Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650072/
https://www.ncbi.nlm.nih.gov/pubmed/34901869
http://dx.doi.org/10.1093/schizbullopen/sgab037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650072/
https://www.ncbi.nlm.nih.gov/pubmed/34901869
http://dx.doi.org/10.1093/schizbullopen/sgab037

Ejemplares similares